# Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)

> **NCT07329257** · — · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 100 (estimated)

## Conditions studied

- Baker Gordon Syndrome
- Rare Neurodevelopmental Conditions
- Rare Neurogenetic Conditions
- Syt-1 Disorder
- Epilepsy
- Seizure
- Genetic Mutations
- Autism in Children
- Developmental Delay (Disorder)

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT07329257
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07329257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07329257, "Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07329257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*